Loading banner…

Moderna VP announced as keynote speaker for 2021 ISPE Facilities of the Future Conference


·

2 min read 2 min

Senior vice president US Manufacturing of Moderna, Scott Nickerson, has been confirmed as a keynote speaker for the hybrid 2021 ISPE Facilities of the Future Conference, taking place on 28 and 29 September in North Bethesda, Maryland.

Nickerson joined Moderna in May 2016 as Head of Quality accountable for all aspects of GxP Quality. Before Moderna, he was with Alexion Pharmaceuticals serving as vice president of Quality Assurance and Quality Control. There, he supported biotech manufacturing for both commercial and clinical products. Nickerson led quality efforts supporting commercialisation of two new rare disease therapies in multiple countries.

Scott Nickerson Moderna
Senior vice president US Manufacturing of Moderna, Scott Nickerson

Global pharmaceutical manufacturing and related regulatory systems

The opening keynote session COVID’s Impact on Pharma Facilities of the Future will take a high-level look ahead at global pharmaceutical manufacturing and related regulatory systems. Nickerson will discuss the impact of COVID on the industry and the applications of future manufacturing operations.

Additional keynote speakers include:

  • David Churchward

Deputy unit manager, Inspectorate Strategy and Innovation MHRA

MHRA Response to COVID19: Taking Learning into Future Regulatory Systems

  • Louis Schmukler

President, Global Product Development & Supply Bristol-Myers Squibb

An Introduction to ISPE Facilities of the Future Conference from the Beginning: A Visionary’s Perspective

Facilities of the future

In addition, representatives from BARDA, Operation Warp Speed, Vaccines Manufacturing & Innovation Centre (VMIC-UK), Bill & Melinda Gates Foundation, and more will round out a compelling line-up of expert speakers. 

Featuring technical presentations from regulatory authorities and industry leaders already planning and building “facilities of the future,” the 2021 ISPE Facilities of the Future Conference will explore topics such as the of patient-specific cell and gene therapy facilities, new developments in the use of artificial intelligence, innovations in treatment and the transforming technologies that produce them, and lessons learned from the COVID-19 era.

To ensure this experience is accessible to all, this will be a hybrid event with virtual components—delivering thought-provoking learning and global networking opportunities whether attendees choose to join us in-person or virtually.

Explore the agenda and register at www.ISPE.org/FOF21.

Stay up to date

Get notified when we publish something new, and unsubscribe at any time.

Loading banner…